Profile
Sector:
HealthcareCountry:
United StatesIPO:
Website:
Next earnings report:
29 November 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Tue, 19 Nov 2024 21:00:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
What type of business is Citius Oncology?
Citius Oncology, Inc. focuses on the development of novel targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adults with relapsed or refractory cutaneous T-cell lymphoma. The company is headquartered in New York, New York.Citius Oncology, Inc. operates as a subsidiary of Citius Pharmaceuticals, Inc.
What sector is Citius Oncology in?
Citius Oncology is in the Healthcare sector
What industry is Citius Oncology in?
Citius Oncology is in the Drug Manufacturers - Specialty & Generic industry
What country is Citius Oncology from?
Citius Oncology is headquartered in United States
Is Citius Oncology in the S&P 500?
No, Citius Oncology is not included in the S&P 500 index
Is Citius Oncology in the NASDAQ 100?
No, Citius Oncology is not included in the NASDAQ 100 index
Is Citius Oncology in the Dow Jones?
No, Citius Oncology is not included in the Dow Jones index
When was Citius Oncology the previous earnings report?
No data
When does Citius Oncology earnings report?
The next expected earnings date for Citius Oncology is 29 November 2024